The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance ... RSV that presents with two or more symptoms at 3.7 months of follow-up – a little ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

Norovirus is highly infectious and causing a lot of illness this winter. Several vaccine candidates are making their way through clinical trials.

Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and ...

A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye ...

Bird flu has now spread to humans in a dozen states after public health officials confirmed an Ohio man had contracted the ...

CASES of a winter illness that causes violent bouts of vomiting and diarrhoea are “way above” what we usually see in the UK at this time of year – and experts are warning what to ...

The pandemic death total stands at 1,252 as of February 1, 2025 (the most recent data available). The 5 reported deaths last ...

A social media post claims that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic. After fact checking, we found that the claim is false. According to an Instagram post, “Moderna ...

This story was originally published in The Highlight, Vox’s member-exclusive magazine. To get early access to ...